Co-Diagnostics, Inc. (CODX) Fair Value 2026

CODX · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.8 /10

32 fundamental signals · 1 models active

Value Trap Risk

WARN (44/100)

Quick Summary — As of 2026-08-28, Co-Diagnostics, Inc. (CODX) trades at $1.21. QOC: 5.8/10. Value Trap Risk: 44/100 (WARN). 1/13 models active.

Key Facts

Ticker
CODX
Price
$1.21
Quality Score
5.8/10
Value Trap Risk
44/100
Models Active
1/13
Last Updated
Strength: ML-RIV suggests +432.5% upside with 53% confidence
Risk: Value Trap score of 44 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give CODX?

1 Intrinsic Value Models vs. Current Price ($1.21)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $6.44 +432.5%

All Models Active

All 1 models are displayed above.

What Is Co-Diagnostics, Inc. (CODX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Co-Diagnostics, Inc. is potentially undervalued at its current price of $1.21. Based on our 13-model framework, Co-Diagnostics, Inc.'s intrinsic value is estimated at a median fair value of $6.44 — representing +432.5% implied upside — with 1 out of 1 active models confirming this thesis.

What Do the Models Say About CODX?

1 of 13 models are currently active for CODX. All 1 active models suggest the stock trades below fair value. See which stocks rank higher →

How Does CODX Rank in Medical Devices?

Among 159 Medical Devices stocks, CODX ranks #100 by Quality of Company score. CirclFi's QOC score of 5.8/10 evaluates 32 fundamental signals. A score of 5.8 reflects mixed fundamentals.

See all Most Undervalued Medical Devices Stocks →

Co-Diagnostics, Inc.'s positioning within the Medical Devices segment means that R&D productivity ratio plays an outsized role in fundamental analysis. The sector's unique characteristics — including licensing and M&A optionality — shape both the opportunity set and risk profile.

Is CODX a Value Trap?

CirclFi's Value Trap algorithm assigns CODX a score of 44/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Co-Diagnostics, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Co-Diagnostics, Inc. earns a quality score of 5.8/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. Our Value Trap detector shows moderate caution signals worth monitoring.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CODX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across CODX's 1 active models, average confidence is 53%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Co-Diagnostics, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

ADMTADM Tronics Unlimited, Inc.QOC 5.8CVCapsoVision, Inc.QOC 5.7QDELQuidelOrtho CorporationQOC 5.8VNRXVolitionRx LimitedQOC 5.7OWLTOwlet, Inc.QOC 5.8TLSITriSalus Life Sciences, Inc.QOC 5.7BJDXBluejay Diagnostics, Inc.QOC 4.4XTNTXtant Medical Holdings, Inc.QOC 8.4GKOSGlaukos CorporationQOC 6.7IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: ADMT · CV · QDEL · VNRX · OWLT · TLSI · BJDX · XTNT · GKOS · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to CODX?

7 companies across all industries closest to CODX’s Quality of Company score of 5.8/10.

FIRYFiry Inc.QOC 5.8BBOTBridgeBio Oncology Therapeutics, Inc.QOC 5.8RMTIRockwell Medical, Inc.QOC 5.8CNDTConduent IncorporatedQOC 5.8AIRIAir Industries GroupQOC 5.8CYNCyngn Inc.QOC 5.8NVDANVIDIA CorporationQOC 10.0

Read investment analysis: FIRY · BBOT · RMTI · CNDT · AIRI · CYN · NVDA

Where Does CODX Sit in CirclFi's Medical Devices Rankings?

CODX is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Co-Diagnostics, Inc.’s Valuation?

What is Co-Diagnostics, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Co-Diagnostics, Inc. (CODX). The Quality of Company score is 5.8/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CODX overvalued or undervalued right now?

At $1.21, 1 of 1 active models suggest CODX may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Co-Diagnostics, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 5.8 mean for CODX?

Co-Diagnostics, Inc.'s QOC of 5.8/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on CODX?

CirclFi analyzes CODX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is CODX a value trap in 2026?

Co-Diagnostics, Inc.'s Value Trap score is 44/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Co-Diagnostics, Inc. (CODX) a Quality of Company score of 5.8/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/CODX/ · Methodology
Primary sources for this CODX valuation
  • Financial statements: Co-Diagnostics, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001692415) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CODX as of ; valuations recomputed .